News on Pfizer (Ticker: PFE) continually updated from thousands of sources around the net.
15 hrs ago | BioResearch Online
The U.S. Food and Drug Administration has requested Regeneron Pharmaceuticals and Sanofi to evaluate how their investigational cholesterol drug affects brain function.
Trending on the Topix Network
20 hrs ago | Investor's Business Daily
The annual meeting of the American Association for Cancer Research, which convenes in San Diego on April 5, is viewed by most drug-industry watchers as a second-tier medical conference.
23 hrs ago | BroadwayWorld.com
Exhibitor's Co-op is a New Jersey based group of artists meeting weekly to critique each other's work and present exhibitions.
Yesterday | Freshnews
The Global Biosimulation market is witnessing increasing collaborations and partnerships between vendors.
Yesterday | Lawsites
How does your state rate in supporting access to justice for those who face economic, language or physical barriers? A new website, The Justice Index , provides a state-by-state scorecard of resources and initiatives designed to ensure that everyone has equal access to the legal system.
Yesterday | WHAS11
NEW YORK, N.Y., March 6 Pfizer Inc. is voluntarily recalling one lot of 30-count Effexor XR 150 mg extended-release capsules, one lot of 90-count Effexor XR 150 mg extended-release capsules and one lot of 90-count Greenstone LLC-branded Venlafaxine HC1 150 mg extended-release capsules.
Ranbaxy Laboratories Ltd. , India 's largest drugmaker, is pulling two batches of its generic version of Pfizer Inc. 's Lipitor drug from the U.S. market, the second recall of the cholesterol lowering medicine in 15 months.
Effexor recall: The Consumerist shows sample pics of the heart drug Tikosyn that may have been mixed with Effexor.
The Wall Street Bull Market Express is leaving the station and you have two months, maybe three to run down the platform, take the leap, and latch on to the caboose.
Regeneron Pharmaceuticals Inc. and Sanofi and must assess how their experimental cholesterol drug affects brain function after U.S. regulators learned of adverse events associated with this new class of medicines.
Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer's Effexor XRA 150 Mg Extended-Release Capsules and One Lot of Greenstone's Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of TikosynA Capsules NEW YORK-- --Pfizer Inc. is voluntarily recalling one lot of 30-count Effexor XRA 150 mg extended-release ... (more)
The Rating Outlook remains St... China Sees More Currency Volatility as Central Bank Seeks to Discourage Idea That Yuan is a "One-Way Trade," Says Market Vectors' Rodilosso )--New willingness from the Chinese Central Bank to let the renminbi depreciate could fundamentally alter what had been a "one-way" trade, and fixed income ETF PM Fran Rodil...
Pfizer Inc said on Thursday it was recalling two lots of its Effexor XR antidepressant and another lot of its generic version of the drug after a pharmacist reported finding one capsule of a different medicine in a bottle of Effexor.
Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings filed by institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission .